Showing 20 of 123 recruiting trials for “Systemic lupus erythematosus”
Safety and Efficacy of ONT01 in Lupus
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases
👨⚕️ Meiping Lu, The Children's Hospital of Zhejiang University School of Medicine📍 1 site📅 Started Mar 2026View details ↗
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
👨⚕️ Qiubai Li, Professor, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Mar 2026View details ↗
Alnuctamab for Refractory SLE (LATTE Study)
👨⚕️ Chrisanna Dobrowolski, MD, Icahn School of Medicine at Mount Sinai School📍 1 site📅 Started Mar 2026View details ↗
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Study of CD19 CAR-T Therapy for Refractory SLE
A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)
RecruitingNCT07330245 ↗
Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus
A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus
👨⚕️ Mengtao Li, PhD, Peking Union Medical College Hospital📍 3 sites📅 Started Dec 2025View details ↗
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Creating Health Course Study for People With Rheumatological Conditions
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus
👨⚕️ Chadwick Prodromos, MD, The Foundation for Orthopaedics and Regenerative Medicine📍 2 sites📅 Started Dec 2025View details ↗
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
🏥 The Children's Hospital of Zhejiang University School of Medicine📍 1 site📅 Started Dec 2025View details ↗
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Page 1 of 7Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →